Previous 10 | Next 10 |
RANCHO CUCAMONGA, CA / ACCESSWIRE / March 3, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2021 ended December 31, 2021, after the market closes on Thursday, March 10 th , 2022, and will hold a conference call t...
Finding growth with Charles Kirkpatrick. Philosophy and style. Prediction versus reaction. For further details see: Kirkpatrick's Growth Screening Strategy
We identified 18 stocks in S&P 500 with strong momentum based on our criteria. Ten of the stocks we identified made new all-time highs. Five of these stocks are 40% or more above their 200-day moving average. For further details see: S&P 500 Stocks With Strong Mo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Don’t expect market volatility to slow down anytime soon. We’re going to be on this ride because on simple market reality: The market doesn’t like uncertainty. And that’s why you need safe stocks...
Amphastar Pharmaceuticals (NASDAQ:AMPH) perks up 4% premarket following an announcement that the FDA has tentatively approved its Abbreviated New Drug Application (ANDA) for Vasopressin injection, USP 20 Units/mL, 1mL Single Dose Vial. Vasopressin is indicated to increase ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / December 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has tentatively approved the Company's Abbreviated New Drug Application ("ANDA") for Vasopressin injection, USP 20 Units/mL, 1mL ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 22, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi...
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2021 Earnings Conference Call November 8, 2021 5:00 PM ET Company Participants Dan Dischner - Vice President, Corporate Communications Bill Peters - Chief Financial Officer Conference Call Participants Jacob Hughes - Wells Fargo Securities Elliot Wilb...
Amphastar Pharmaceuticals (NASDAQ:AMPH): Q3 Non-GAAP EPS of $0.46 beats by $0.23; GAAP EPS of $0.59. Revenue of $112.19M (+34.5% Y/Y) beats by $9.39M. Press Release For further details see: Amphastar Pharmaceuticals EPS beats by $0.23, beats on revenue
Reports Net Revenues of $112.2 Million for the Three Months Ended September 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2021. ...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...